Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride can improve hair loss in women, but more research is needed.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Younger people (median age 35) experience more PFS-like symptoms with 1mg finasteride; more research needed.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

Oral finasteride may cause more sexual side effects than expected, possibly due to negative publicity and reporting bias.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatments.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Post-finasteride syndrome can cause sexual and systemic side effects, and patients should be informed about these risks.

Finasteride may help treat female hair loss, but has risks.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

5-ARI therapy may help prevent prostate cancer progression.

Urologists should screen for mental health issues before and during finasteride treatment.

Lower finasteride doses had more side effects; dutasteride caused back pain; more research needed on post-finasteride syndrome.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Post-finasteride syndrome is rarely linked to sexual and systemic side effects.

Finasteride may cause depression and suicidal thoughts, especially in young men.

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.